TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 23382484

Group type: EXPERIMENTAL
Intervention: 50mg sildenafil (PDE5 inhibitor)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15

Group type: COMPARATOR
Intervention: 25mg hydralazine (control, cGMP-independent vasodilator)
Number of subjects: 15
Study: 21281875

Group type: EXPERIMENTAL
Intervention: Active grass pollen immunotherapy (n = 7)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Placebo (n = 6)
Number of subjects: 13
Study: 19457484

Group type: EXPERIMENTAL
Intervention: Red wine
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Glycerol + ethanol
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Fructose
Number of subjects: 10

Group type: COMPARATOR
Intervention: Water (control)
Number of subjects: 10
Study: 16515093

Group type: EXPERIMENTAL
Intervention: Bio‐Oss
Number of subjects: 9

Group type: COMPARATOR
Intervention: Control (no Bio‐Oss)
Number of subjects: 9
Study: 15607396

Group type: EXPERIMENTAL
Intervention: Sildenafil (50 mg)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 11006178

Group type: EXPERIMENTAL
Intervention: Micronized 17 beta‐oestradiol 2 mg and norethisterone acetate 1 mg/day per os
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Alendronate 10 mg/day per os
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Micronized 17 beta‐oestradiol 2 mg, norethisterone acetate 1 mg/day per os and alendronate 10 mg/day per os
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control group (HRT only)
Number of subjects: 120

Group type: COMPARATOR
Intervention: All groups (including control)
Number of subjects: 120
Study: 9276782

Group type: EXPERIMENTAL
Intervention: Relaxation audiotapes
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Neutral audiotapes
Number of subjects: 0
Study: 8510897

Group type: EXPERIMENTAL
Intervention: Normal fundus on admission
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Papilledema
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Retinal edema outside the posterior vascular arcades
Number of subjects: 56
Study: 2436414

Group type: EXPERIMENTAL
Intervention: PUVA treatment
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: UVB treatment
Number of subjects: 35

Group type: COMPARATOR
Intervention: Untreated hands (control)
Number of subjects: 35
Study: 31630870

Group type: EXPERIMENTAL
Intervention: Inclisiran 300 mg
Number of subjects: 278

Group type: EXPERIMENTAL
Intervention: Inclisiran 300 mg single-dose
Number of subjects: 278

Group type: EXPERIMENTAL
Intervention: Inclisiran 300 mg 2-dose
Number of subjects: 278

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 278
Study: 30378591

Group type: EXPERIMENTAL
Intervention: BIS monitoring during anesthesia
Number of subjects: 81

Group type: COMPARATOR
Intervention: Standard intraoperative hemodynamic monitoring (non-BIS group)
Number of subjects: 81
Study: 26621218

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT)
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: Sertraline (flexible-dose treatment)
Number of subjects: 400

Group type: COMPARATOR
Intervention: Engagement Interview
Number of subjects: 400

Group type: COMPARATOR
Intervention: Control visit
Number of subjects: 400

Group type: COMPARATOR
Intervention: No treatment (longitudinal cohort)
Number of subjects: 400
Study: 24430407

Group type: EXPERIMENTAL
Intervention: 50 × 10⁶ allogeneic mesenchymal stem cells
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: 150 × 10⁶ allogeneic mesenchymal stem cells
Number of subjects: 55

Group type: COMPARATOR
Intervention: sodium hyaluronate (control)
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: mesenchymal stem cells
Number of subjects: 55
Study: 22754044

Group type: EXPERIMENTAL
Intervention: 5.5‐hr nighttime sleep opportunity
Number of subjects: 18
Study: 20357692

Group type: EXPERIMENTAL
Intervention: Self-selected eating (PAT)
Number of subjects: 143

Group type: COMPARATOR
Intervention: Lipase directed (LIP)
Number of subjects: 143
Study: 18684247

Group type: EXPERIMENTAL
Intervention: Triggered atrial pacing (PAC Suppression, Post‐PAC Response, and Post‐Exercise Response)
Number of subjects: 171

Group type: COMPARATOR
Intervention: Combined group (continuous and triggered atrial pacing with Pace Conditioning)
Number of subjects: 171

Group type: EXPERIMENTAL
Intervention: Triggered group after crossover
Number of subjects: 171

Group type: COMPARATOR
Intervention: Combined group after crossover
Number of subjects: 171
Study: 16105425

Group type: EXPERIMENTAL
Intervention: Low tidal volume ventilation with recruitment maneuvers (RM)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Low tidal volume ventilation without recruitment maneuvers (non-RM group)
Number of subjects: 28
Study: 12682804

Group type: EXPERIMENTAL
Intervention: Cisapride 0.2 mg/kg orally every 6 h (group A)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Cisapride 0.1 mg/kg orally every 3 h (group B)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Both groups (A and B)
Number of subjects: 31
Study: 10597336

Group type: EXPERIMENTAL
Intervention: Infliximab
Number of subjects: 2

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2
Study: 8607306

Group type: EXPERIMENTAL
Intervention: Epidural group (15 ml of bupivacaine 0.75% via thoracic epidural route)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Papaveretum group (20‐30 mg of papaveretum i.v.)
Number of subjects: 16
Study: 1709600

Group type: EXPERIMENTAL
Intervention: Triple drug regimen (rifampicin, isoniazid, pyrazinamide or thiacetazone)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Triple drug regimen (rifampicin, isoniazid)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Rifampicin and isoniazid
Number of subjects: 90

Group type: COMPARATOR
Intervention: Single-drug therapy with isoniazid
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Follow-up after therapy
Number of subjects: 90
Study: 7029975

Group type: EXPERIMENTAL
Intervention: Postoperative telecobalt irradiation of the minor pelvis (50 to 52 Gy)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Radical surgery (Wertheim‐Meigs)
Number of subjects: 120
Study: 30699054

Group type: EXPERIMENTAL
Intervention: E-cigarette starter pack (a second‐generation refillable e‐cigarette with one bottle of nicotine e‐liquid [18 mg per milliliter])
Number of subjects: 886

Group type: COMPARATOR
Intervention: Nicotine-replacement products of their choice
Number of subjects: 886

Group type: EXPERIMENTAL
Intervention: E-cigarette group
Number of subjects: 886

Group type: COMPARATOR
Intervention: Nicotine-replacement group
Number of subjects: 886

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 886
Study: 28143481

Group type: EXPERIMENTAL
Intervention: Serum IL-22 levels
Number of subjects: 504

Group type: EXPERIMENTAL
Intervention: Cardiometabolic risk factors
Number of subjects: 504
Study: 25534776

Group type: EXPERIMENTAL
Intervention: Lactobacillus casei rhamnosus (8×10 colony-forming unit per day) for 6 months
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Neomycin (25 mg · kg · day for 4 days/wk) for 6 months
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (historical control, no prophylaxis)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Lactobacillus casei rhamnosus
Number of subjects: 20
Study: 24338190

Group type: EXPERIMENTAL
Intervention: Inpatient cardiac rehabilitation
Number of subjects: 60

Group type: COMPARATOR
Intervention: Conventional treatments (Control)
Number of subjects: 60
Study: 22027083

Group type: EXPERIMENTAL
Intervention: Right bundle branch block (RBBB)
Number of subjects: 6676

Group type: EXPERIMENTAL
Intervention: Left bundle branch block (LBBB)
Number of subjects: 6676

Group type: COMPARATOR
Intervention: No bundle branch block (BBB)
Number of subjects: 6676

Group type: EXPERIMENTAL
Intervention: Right bundle branch block (RBBB) with reduced left ventricular (LV) systolic function
Number of subjects: 6676

Group type: EXPERIMENTAL
Intervention: Left bundle branch block (LBBB) with preserved left ventricular (LV) systolic function
Number of subjects: 6676
Study: 19159944

Group type: EXPERIMENTAL
Intervention: Enzyme replacement therapy (ERT) with recombinant arylsulfatase B (Naglazyme)
Number of subjects: 7
Study: 17968979

Group type: EXPERIMENTAL
Intervention: Moxonidine
Number of subjects: 141

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 141
Study: 15308475

Group type: EXPERIMENTAL
Intervention: Luteal phase lysine intake (37.7 mg.kg(‐1).day(‐1))
Number of subjects: 5

Group type: COMPARATOR
Intervention: Follicular phase lysine intake (35.0 mg.kg(‐1).day(‐1))
Number of subjects: 5
Study: 11268025

Group type: EXPERIMENTAL
Intervention: Proximal stimulation of nerve segments
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Distal stimulation of nerve segments
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Proximal and distal stimulation of nerve segments
Number of subjects: 86
Study: 9273984

Group type: EXPERIMENTAL
Intervention: Social support, education, or a combination of education and social support
Number of subjects: 363

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 363
Study: 8197893

Group type: EXPERIMENTAL
Intervention: Alcohol Expectancy Questionnaire Tension Reduction Scale
Number of subjects: 0
Study: 3066518

Group type: EXPERIMENTAL
Intervention: Norfloxacin prophylaxis
Number of subjects: 65

Group type: COMPARATOR
Intervention: Control group (no prophylaxis)
Number of subjects: 65
Study: 2083046

Group type: EXPERIMENTAL
Intervention: Mouthrinse containing 0.03% triclosan and 0.25% copolymer of methoxyethylene and maleic acid
Number of subjects: 47

Group type: COMPARATOR
Intervention: Water placebo mouthrinse
Number of subjects: 47
Study: 1093352

Group type: EXPERIMENTAL
Intervention: Betamethasone 17-Valerate steroid aerosol
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Betamethasone 17-Valerate
Number of subjects: 18
Study: 31211805

Group type: EXPERIMENTAL
Intervention: Ketoprofen (3 mg/kg body weight, intravenous)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Isotonic sterile saline solution (control)
Number of subjects: 41
Study: 28026901

Group type: EXPERIMENTAL
Intervention: Supervised twice‐weekly resistance exercise training and 150 min/wk of aerobic exercise
Number of subjects: 121

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 121
Study: 26342247

Group type: EXPERIMENTAL
Intervention: Calcium ionophore solution (GM508 Cult‐Active) for 15 minutes after intracytoplasmic sperm injection
Number of subjects: 296

Group type: COMPARATOR
Intervention: Control group (no calcium ionophore treatment)
Number of subjects: 296
Study: 23433446

Group type: EXPERIMENTAL
Intervention: Weekly paclitaxel plus S‐1 (TS)
Number of subjects: 240

Group type: COMPARATOR
Intervention: Paclitaxel plus 5‐fluorouracil/calcium folinate (TLF)
Number of subjects: 240
Study: 22340792

Group type: EXPERIMENTAL
Intervention: Insulin local injection
Number of subjects: 32
Study: 19570601

Group type: EXPERIMENTAL
Intervention: e-learning program (monthly use for one year)
Number of subjects: 79

Group type: COMPARATOR
Intervention: Control group (no e-learning program)
Number of subjects: 79
Study: 16757701

Group type: EXPERIMENTAL
Intervention: Liquid-based cytology and HPV testing using Hybrid Capture 2 assay
Number of subjects: 33364

Group type: EXPERIMENTAL
Intervention: HPV testing alone at > or = 1 pg/mL
Number of subjects: 33364

Group type: EXPERIMENTAL
Intervention: HPV testing alone at > or = 2 pg/mL
Number of subjects: 33364

Group type: EXPERIMENTAL
Intervention: Liquid-based cytology alone
Number of subjects: 33364

Group type: COMPARATOR
Intervention: Conventional cytology
Number of subjects: 33364
Study: 15075657

Group type: EXPERIMENTAL
Intervention: Abdominal wall lift (AWL)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Positive-pressure capnoperitoneum (PPCpn)
Number of subjects: 40
Study: 11255519

Group type: EXPERIMENTAL
Intervention: Genotypic resistance testing and clinical judgment after initial treatment failure (secondary resistance testing)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Genotypic resistance testing and clinical judgment before initiation of antiretroviral therapy (primary resistance testing)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Secondary resistance testing
Number of subjects: 0

Group type: COMPARATOR
Intervention: Primary resistance testing
Number of subjects: 0
Study: 7970014

Group type: EXPERIMENTAL
Intervention: Tizanidine (24 to 36 mg daily in three doses)
Number of subjects: 187

Group type: EXPERIMENTAL
Intervention: Tizanidine
Number of subjects: 187

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 187
Study: 3118725

Group type: EXPERIMENTAL
Intervention: Single-dose piperacillin
Number of subjects: 94

Group type: COMPARATOR
Intervention: Triple-dose cefoxitin
Number of subjects: 94
Study: 31346621

Group type: EXPERIMENTAL
Intervention: Vollure (Juvéderm Vollure XC)
Number of subjects: 123

Group type: COMPARATOR
Intervention: Control filler
Number of subjects: 123
Study: 31102373

Group type: EXPERIMENTAL
Intervention: Shape intervention (digital weight gain prevention intervention)
Number of subjects: 91
Study: 28645960

Group type: EXPERIMENTAL
Intervention: Physiotherapy (PT) group received seven PT sessions (one preoperative and six postoperative) incorporating education, manual therapy, and a progressive rehabilitation programme of home, aquatic, and gym exercises.
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group did not undertake PT rehabilitation.
Number of subjects: 30
Study: 25254356

Group type: EXPERIMENTAL
Intervention: Intra-aortic balloon counterpulsation (IABP)
Number of subjects: 149

Group type: COMPARATOR
Intervention: Control group (no IABP)
Number of subjects: 149
Study: 23381178

Group type: COMPARATOR
Intervention: Conventional preoperative localization methods (palpation method and Kirschner wire method)
Number of subjects: 220

Group type: EXPERIMENTAL
Intervention: Novel preoperative locator
Number of subjects: 220
Study: 21692613

Group type: EXPERIMENTAL
Intervention: TPMT genotyping prior to azathioprine treatment
Number of subjects: 333

Group type: COMPARATOR
Intervention: No TPMT genotyping prior to azathioprine treatment
Number of subjects: 333

Group type: EXPERIMENTAL
Intervention: TPMT heterozygotes
Number of subjects: 333

Group type: EXPERIMENTAL
Intervention: TPMT variant homozygosity
Number of subjects: 333
Study: 19058489

Group type: EXPERIMENTAL
Intervention: Low calorie diet A
Number of subjects: 96

Group type: COMPARATOR
Intervention: Low calorie diet B
Number of subjects: 96
Study: 16822119

Group type: EXPERIMENTAL
Intervention: Immediate 2-session MET intervention
Number of subjects: 97

Group type: COMPARATOR
Intervention: 3-month delay condition (Control)
Number of subjects: 97
Study: 12589448

Group type: EXPERIMENTAL
Intervention: Diluters that are similar in terms of visual complexity
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Single distractors (diluters)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pre-cued position of the color bar
Number of subjects: 0
Study: 10227081

Group type: EXPERIMENTAL
Intervention: 5 mg dexamethasone
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 9772611

Group type: EXPERIMENTAL
Intervention: Shuizhi-Dahuang mixture with low dosage of antipsychotic drugs
Number of subjects: 67

Group type: COMPARATOR
Intervention: Antipsychotic drugs only (control group)
Number of subjects: 67
Study: 1877599

Group type: EXPERIMENTAL
Intervention: Two blood pressure measurements taken 30 seconds apart using a random-zero sphygmomanometer
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Duplicate blood pressure measurements made by different observers
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Use of random-zero sphygmomanometer in restricted blood pressure ranges
Number of subjects: 0
Study: 6854157

Group type: EXPERIMENTAL
Intervention: Faculty assessments of student case histories
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Faculty evaluations influenced by a halo effect
Number of subjects: 16
Study: 30591577

Group type: EXPERIMENTAL
Intervention: Safe Delivery App (SDA)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Standard practice (control)
Number of subjects: 64
Study: 27814259

Group type: COMPARATOR
Intervention: Standard medical history questionnaire (n = 107)
Number of subjects: 209

Group type: EXPERIMENTAL
Intervention: Medical history questionnaire with additional item about dietary supplement use (n = 102)
Number of subjects: 209

Group type: EXPERIMENTAL
Intervention: Age group analysis
Number of subjects: 209
Study: 24563270

Group type: EXPERIMENTAL
Intervention: Phosphate binder therapy adherence measurement over 2 months
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: Adherent patients
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: Determinants for adherence
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: Social support and quality of life physical score
Number of subjects: 135
Study: 21992583

Group type: EXPERIMENTAL
Intervention: Vinyasa yoga (twice-weekly program)
Number of subjects: 55

Group type: COMPARATOR
Intervention: General health and wellness program (contact control)
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Vinyasa yoga
Number of subjects: 55
Study: 19737297

Group type: EXPERIMENTAL
Intervention: Eccentric strength training (6-week progressive resistance-strengthening programme, 3 times a week)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Eccentric strength training
Number of subjects: 14

Group type: COMPARATOR
Intervention: Control group (waiting control)
Number of subjects: 14
Study: 18692646

Group type: EXPERIMENTAL
Intervention: Electrocautery and collagen patches (TachoSil)
Number of subjects: 20
Study: 15960407

Group type: EXPERIMENTAL
Intervention: 50% nitrous oxide in oxygen along with lignocaine 40 mg mixed in 1% propofol 20 ml (Group NL)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: 50% nitrous oxide in oxygen without lignocaine in propofol (Group N)
Number of subjects: 90

Group type: COMPARATOR
Intervention: 50% oxygen in air with lignocaine mixed in propofol 40 mg (Group L)
Number of subjects: 90
Study: 12912716

Group type: EXPERIMENTAL
Intervention: Direct-to-consumer advertising (DTCA) patient scenario
Number of subjects: 1784

Group type: COMPARATOR
Intervention: Drug reference book patient scenario
Number of subjects: 1784
Study: 9527556

Group type: EXPERIMENTAL
Intervention: PLA barrier
Number of subjects: 30

Group type: COMPARATOR
Intervention: ePTFE barrier
Number of subjects: 30
Study: 7574752

Group type: EXPERIMENTAL
Intervention: Intraperitoneal cisplatin (CDDP) chemotherapy, 100 mg of CDDP and 300 ml of saline administered intraperitoneally just after operation for curatively resected patients; same doses for patients with ascites after removal of fluid.
Number of subjects: 12

Group type: COMPARATOR
Intervention: Intraperitoneal cisplatin (CDDP) chemotherapy for patients with ascites.
Number of subjects: 12
Study: 2132185

Group type: EXPERIMENTAL
Intervention: Slow release formulation of bezafibrate (Bezalip Mono)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 340327

Group type: EXPERIMENTAL
Intervention: Cimetidine (1200 mg daily)
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Cimetidine (800 mg daily)
Number of subjects: 94

Group type: COMPARATOR
Intervention: Intensive regimen of Al‐Mg antacid (210 ml daily)
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Cimetidine (both dosages)
Number of subjects: 94

Group type: COMPARATOR
Intervention: Intensive regimen of Al‐Mg antacid
Number of subjects: 94

Group type: COMPARATOR
Intervention: Antacid treatment
Number of subjects: 94
Study: 30427698

Group type: EXPERIMENTAL
Intervention: Six 1-g NaCl tablets (salt intervention trial)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo trial (six flour tablets)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Treadmill walking post sodium ingestion
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: DXA scan quantification
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Total body BMC after sodium ingestion
Number of subjects: 14
Study: 27854539

Group type: EXPERIMENTAL
Intervention: CHW-led health literacy intervention with tailored cancer-screening brochure, training, and monthly counseling.
Number of subjects: 560
Study: 25536489

Group type: EXPERIMENTAL
Intervention: Vertical vibration (VV)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control (CON)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Rotational vibration (RV)
Number of subjects: 12
Study: 23652897

Group type: EXPERIMENTAL
Intervention: SGP‐HA filler (Restylane®)
Number of subjects: 20
Study: 21078916

Group type: EXPERIMENTAL
Intervention: Depression-reducing program (8 sessions, 1 hour each)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Control group (no intervention specified)
Number of subjects: 58
Study: 19015933

Group type: EXPERIMENTAL
Intervention: PerFix Plug (P)
Number of subjects: 472

Group type: EXPERIMENTAL
Intervention: Prolene Hernia System (PHS)
Number of subjects: 472

Group type: COMPARATOR
Intervention: Lichtenstein mesh (L)
Number of subjects: 472

Group type: EXPERIMENTAL
Intervention: All techniques
Number of subjects: 472
Study: 17546380

Group type: EXPERIMENTAL
Intervention: Odontogain ultrasonic scaler (group A)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Prophy Max ultrasonic scaler (group B)
Number of subjects: 20
Study: 15101004

Group type: EXPERIMENTAL
Intervention: Cuirass application and biphasic extra-thoracic ventilation
Number of subjects: 10

Group type: COMPARATOR
Intervention: Endotracheal (ET) intubation and manual ventilation
Number of subjects: 10
Study: 11515277

Group type: EXPERIMENTAL
Intervention: O + S active (Onset 12/89%, Stability 30 ms)
Number of subjects: 103

Group type: COMPARATOR
Intervention: O + S inactive
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: EGW passive with O + S inactive
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: EGW passive with O + S active
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: O + S active
Number of subjects: 103
Study: 9649996

Group type: EXPERIMENTAL
Intervention: Epidural analgesia with morphine-bupivacaine combination (Group A)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Placebo (saline) (Group B)
Number of subjects: 44
Study: 8530314

Group type: EXPERIMENTAL
Intervention: Oral amoxicillin plus clavulanic acid
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Oral sulfamethoxazol and trimethoprim
Number of subjects: 130

Group type: COMPARATOR
Intervention: No perioperative antibiotics
Number of subjects: 130
Study: 2151141

Group type: EXPERIMENTAL
Intervention: Breast self-examination (BSE) practice
Number of subjects: 1315

Group type: EXPERIMENTAL
Intervention: Optimal BSE practice
Number of subjects: 1315

Group type: COMPARATOR
Intervention: Radical surgery
Number of subjects: 1315